Skip to main content
. 2017 Mar 6;7(3):e012187. doi: 10.1136/bmjopen-2016-012187

Figure 2.

Figure 2

Cost-effectiveness acceptability curve of the PACT intervention compared to usual care, for patients with breast cancer. Note that the intervention is dominant for patients with colon cancer. Therefore, generation of a cost-effectiveness acceptability curve became redundant. ICER, incremental cost-effectiveness ratio; PACT, physical activity during cancer treatment.